Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak.
Adult
Anti-Retroviral Agents
/ therapeutic use
Betacoronavirus
COVID-19
Coronavirus Infections
/ diagnosis
Cough
/ virology
Dyspnea
/ virology
Fatigue
/ virology
Female
Fever
/ virology
Gastric Bypass
Humans
Hydroxychloroquine
/ therapeutic use
Immunosuppressive Agents
/ therapeutic use
Iran
/ epidemiology
Male
Middle Aged
Off-Label Use
Pandemics
Patient Readmission
/ statistics & numerical data
Pneumonia, Viral
/ diagnosis
Postoperative Complications
SARS-CoV-2
Bariatric surgery
COVID-19
Complications
Coronavirus
Gastric bypass
Pneumonia
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
22
4
2020
medline:
11
8
2020
entrez:
22
4
2020
Statut:
ppublish
Résumé
There is no data on patients with severe obesity who developed coronavirus disease 2019 (COVID-19) after bariatric surgery. Four gastric bypass operations, performed in a 2-week period between Feb 24 and March 4, 2020, in Tehran, Iran, were complicated with COVID-19. The mean age and body mass index were 46 ± 12 years and 49 ± 3 kg/m
Identifiants
pubmed: 32314249
doi: 10.1007/s11695-020-04617-x
pii: 10.1007/s11695-020-04617-x
pmc: PMC7168566
doi:
Substances chimiques
Anti-Retroviral Agents
0
Immunosuppressive Agents
0
Hydroxychloroquine
4QWG6N8QKH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3624-3627Commentaires et corrections
Type : CommentIn
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Ann Surg. 2020 Jul;272(1):e27-e29
pubmed: 32221117
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Diabetes Obes Metab. 2015 Feb;17(2):198-201
pubmed: 25352176
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Surg Obes Relat Dis. 2018 May;14(5):652-657
pubmed: 29503096
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Blood Purif. 2020;49(3):255-258
pubmed: 32172242
Nat Biotechnol. 2020 Apr;38(4):379-381
pubmed: 32205870